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Cellular Distribution of Anionic Antimicrobial Peptide in Normal Lung
and during Acute Pulmonary Inflammation
Abstract
Anionic peptides (APs) are small antimicrobial peptides present in human and ovine lung. In this study APs
were also detected in bovine lung, and production of APs in lungs with acute inflammation induced by various
stimuli was determined. The distribution and intensity of APs were determined by immunohistochemistry in
lungs of 1) neonatal calves (1-3 days of age) inoculated with Mannheimia (Pasteurella) haemolytica, a known
inducer of the bovine β-defensin lingual antimicrobial peptide (LAP) or pyrogen-free saline (PFS), and 2)
growing calves (3 months of age) similarly inoculated with M. haemolytica, a lipopolysaccharide (LPS) from
M. haemolytica, an LPS-associated protein from M. haemolytica, or PFS. APs were also detected by western
blots with the same antibody in lungs of the calves above, as well as in calves inoculated with Pseudomonas
aeruginosa, and an adult cow. Anionic peptide (AP) immunoreactivity was detected in bands (approximate
weights) in the western blots of lung at 28-30 (strongest signal), 31, 45, and 52-60 kd regardless of inoculum.
The adult cow lacked bands at 45 kd, but it had additional bands at 64 (inconsistently) and 35-38 kd. All these
band sizes are consistent with those of the western blots of human and ovine lung. The cellular distribution of
APs in lung of neonatal and growing cattle was similar to that in lung of human and sheep. In lungs with acute
inflammation induced by live bacteria, LPS, or protein, AP distribution and intensity were similar to those in
control (PFS-inoculated) lungs and slightly decreased in bronchioles. This work demonstrates that AP is
present in lung of cattle and is thereby conserved among two ruminant species and man. Distribution and
intensity of AP production are not enhanced by infection or acute inflammation and are decreased in
bronchioles, which suggests that AP is not induced like β-defensins such as LAP, but, instead, is produced
constitutively.
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Normal Lung and during Acute Pulmonary Inflammation
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Abstract. Anionic peptides (APs) are small antimicrobial peptides present in human and ovine lung. In this
study APs were also detected in bovine lung, and production of APs in lungs with acute inflammation induced
by various stimuli was determined. The distribution and intensity of APs were determined by immunohisto-
chemistry in lungs of 1) neonatal calves (1–3 days of age) inoculated with Mannheimia (Pasteurella) haemo-
lytica, a known inducer of the bovine -defensin lingual antimicrobial peptide (LAP) or pyrogen-free saline
(PFS), and 2) growing calves (3 months of age) similarly inoculated with M. haemolytica, a lipopolysaccharide
(LPS) from M. haemolytica, an LPS-associated protein from M. haemolytica, or PFS. APs were also detected
by western blots with the same antibody in lungs of the calves above, as well as in calves inoculated with
Pseudomonas aeruginosa, and an adult cow. Anionic peptide (AP) immunoreactivity was detected in bands
(approximate weights) in the western blots of lung at 28–30 (strongest signal), 31, 45, and 52–60 kd regardless
of inoculum. The adult cow lacked bands at 45 kd, but it had additional bands at 64 (inconsistently) and 35–
38 kd. All these band sizes are consistent with those of the western blots of human and ovine lung. The cellular
distribution of APs in lung of neonatal and growing cattle was similar to that in lung of human and sheep. In
lungs with acute inflammation induced by live bacteria, LPS, or protein, AP distribution and intensity were
similar to those in control (PFS-inoculated) lungs and slightly decreased in bronchioles. This work demonstrates
that AP is present in lung of cattle and is thereby conserved among two ruminant species and man. Distribution
and intensity of AP production are not enhanced by infection or acute inflammation and are decreased in
bronchioles, which suggests that AP is not induced like -defensins such as LAP, but, instead, is produced
constitutively.
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Because of the close association of respiratory mu-
cosa to environmental substances, innate defense
mechanisms exist, at least in part, to protect the host
against microbial colonization and infection. These
mechanisms include the mucociliary apparatus, surfac-
tant and surfactant proteins, alveolar macrophages, and
an intact epithelium. Recently, several classes of an-
timicrobial proteins and peptides (AMP) produced by
respiratory mucosal cells have become increasingly
appreciated because of their contribution to innate de-
fense against microbial pathogens.9,13,16,22 These in-
clude peroxidase, lactoferrin, lysozyme, bacterial per-
meability–inducing protein-1, phospholipase A2, se-
cretory leukoprotease inhibitor, defensins, and cathel-
icidins.9,13,22 Expression of some of these, notably the
human cathelicidin LL3712 and human -defensin-2
and -3 (HBD 2, 3  peptide; DEFB 2, 3  gene),19,22
tracheal antimicrobial peptide (TAP)10,20 and lingual
antimicrobial peptide (LAP)20–23 of cattle, mouse -de-
fensin-3 (MBD-3)1 and rat -defensin-2 (RBD-2),17 is
induced or potentially induced by inflammation. Brog-
den et al.2,4,7 have determined that a class of peptides
with anionic properties also has antimicrobial activity
and is produced by epithelial cells of lung of sheep
and humans. Anionic peptide (AP) production during
bacterial pneumonia or in response to inflammatory
stimuli has not been fully characterized in any species
but has recently been shown to be decreased in alve-
olar epithelium and bronchoalveolar lavage fluid
(BALF) from lungs of humans with cystic fibrosis6 and
increased in the cytoplasm of hyperplastic cells during
chronic pneumonia of sheep.11
APs are distinct from many AMPs for the following
reasons: they are small, they are anionic because of
homopolymeric regions of aspartate, they require zinc
as a cofactor for bactericidal activity, and they are pre-
sent in pulmonary surfactant.4,6,7 It has been suggested
that APs are products of posttransitional cleavage of a
larger peptide, such as a zymogen.7 The identity of the
mature protein product from which APs are cleaved is
not yet known. Similar to other AMPs, APs are bac-
tericidal against Gram-positive and Gram-negative or-
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ganisms. Efficacy of AP microbial killing is inversely
proportional to the number of aspartate residues in the
peptide.4,7 The mechanism of bacterial killing has not
been fully elucidated but is thought to involve the bac-
terial uptake of APs and zinc. AP bactericidal activity
is inhibited in the presence of phosphates or ethylene-
diaminetetraacetic acid, but they have increased anti-
microbial activity with increasing concentrations of
NaCl.4,18 Recent work indicates the presence of larger
AP-containing proteins in the trachea, nasal epitheli-
um, liver, and small intestine of sheep.5 Degenerate
oligonucleotides were synthesized to identify precur-
sor genes for APs in sheep genomic DNA; these
probes hybridized with larger sequences, further indi-
cating the likelihood that APs are precursor portions
of a zymogen.4,5 AP has been detected in BALF from
neonatal and adult cattle by enzyme-linked immuno-
sorbent assay (ELISA), and the percent killing of APs
in BALF from adult cattle (n  11) ranged from 23%
to 75% (60.2% average) in a dilution susceptibility
test.8 But cellular production of AP in bovine lung has
not been previously assessed. Bovine respiratory epi-
thelial cells produce at least two -defensin antimicro-
bial peptides, TAP and LAP, which are induced by
inflammatory mediators.20–23 Of these, LAP mRNA ex-
pression is markedly increased during infection with
the ruminant respiratory pathogen Mannheimia (Pas-
teurella) haemolytica.23 Both M. haemolytica LPS and
an LPS-associated peptide (LPS-P) also induce inflam-
mation in this model.3
The purpose of this study was to assess the cellular
distribution and intensity of AP production in lung
during an acute inflammatory response induced either
by a live M. haemolytica or by bacterial products
(LPS, LPS-P). We assessed the presence of APs in
healthy and inflamed lung of neonatal and growing (3
months old) calves, ages at which human infants and
other mammalian species are particularly susceptible
to microbial infection.
Materials and Methods
Animals and tissues
Eight healthy male Holstein calves were deprived of co-
lostrum and brought to the Iowa State University Laboratory
Animal Resources facility within 24 hours of birth. Four
animals each were inoculated with 5 ml of live M. haemo-
lytica (1.55  109 CFU) or pyrogen-free saline (PFS) in the
primary bronchus of the right cranial lung lobe by fiberoptic
bronchoscopy and euthanatized 6 hours after inoculation.
Colostrum-deprived, neonatal calves did not survive up to
24 hours after inoculation with M. haemolytica and were,
therefore, euthanatized 6 hours after inoculation. In addition,
eight male Holstein calves, 3 months of age, were similarly
inoculated in the primary bronchus of the right cranial lung
lobe by fiberoptic bronchoscopy with M. haemolytica, M.
haemolytica LPS, M. haemolytica LPS-P, or PFS (two calves
per inoculum) and euthanatized 24 hours after inoculation.
From each animal of each age group (neonatal and 3
months old), sections of lung were taken from each inocu-
lated lung lobe and fixed in 10% neutral-buffered formalin
for immunohistochemical detection of APs. Lung tissue col-
lected 6 hours after inoculation from neonatal calves inoc-
ulated intrabronchially with either PFS or M. haemolytica,
as well as lung tissue collected 4 hours after inoculation with
Pseudomonas aeruginosa (included to compare two different
Gram-negative bacteria), killed P. aeruginosa, or P. aeru-
ginosa LPS, and lung tissue collected from one healthy, un-
inoculated adult cow (1 cm3/sample, two samples per ani-
mal) were frozen immediately in liquid nitrogen and stored
in a 70 C freezer for western blot analysis.
Antianionic peptide monoclonal antibody (IG9-IC2)
Antianionic peptide monoclonal IgG was produced by
Brogden et al.4,7 in CF1 mice against the synthetic peptide
H–DDDDDDD–OH conjugated to keyhole limpet hemocy-
anin. This peptide was synthesized on the basis of the se-
quence of APs isolated from sheep BAL fluid.4,7
Western blot analysis
Lung tissue was homogenized in chilled 0.14 M NaCl and
then boiled for 5 minutes after addition of reducing sample
buffer (ImmunoPure Reducing Lane Marker Buffer, Pierce,
Rockford, IL). Twenty microliters of a 1 : 10 dilution (lung
sample/1 lane marker buffer) was loaded per lane. Broad-
range sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS-PAGE) molecular weight standards (Bio-
Rad, Hercules, CA) were run in two lanes per gel. SDS-
PAGE was performed with 4% stacking and 12% resolving
precast mini-gels (BioRad) run at 100 V for 90 minutes.
Proteins were transferred to polyvinylidene difluoride
(PVDF) membranes (Immobilon-P, Millipore Corporation,
Bedford, MA) by electroblotting (30 V for 16 hours). Pri-
mary antibody (mouse anti-AP IgG) was applied at a con-
centration of 5 g/ml (1 : 200 dilution) to the PVDF mem-
branes. Secondary antibody was goat anti-mouse IgG con-
jugated with alkaline phosphatase (Kirkegaard & Perry Lab-
oratories, Gaithersburg, MD) used at 0.5 g/ml (1 : 2000).
The blots were incubated with peroxidase chromagen (Kir-
kegaard & Perry Laboratories) for 5 minutes. The western
blots were graded by the presence or absence of immuno-
reactive bands; molecular weights of bands were estimated
by broad-range SDS-PAGE molecular weight standards
(BioRad). Lung tissue from a healthy adult cow was in-
cluded in the event that lung tissue of neonatal cattle lacked
anionic peptide immunoreactivity (AP-IR).
Anionic peptide immunohistochemistry
Briefly, slides were deparaffinized, rinsed with ultrapure
water, subjected to antigen retrieval (microwaved for 10
minutes in pH 10.0 Tris buffer), and then placed in a 20
C freezer for 15 minutes. Slides were washed in TNTB buff-
er (0.05 M Tris, 0.85% NaCl, 0.05% Tween, 1% bovine
serum albumin [BSA]) and then incubated with mouse anti-
AP IgG (1 : 700) overnight in a humidified chamber at 4 C.
Slides were rinsed with TNTB the next morning and incu-
708 Vet Pathol 39:6, 2002Fales-Williams, Brogden, Huffman, Gallup, and Ackermann
Fig. 1. The western blots of homogenized lung tissue
from neonatal calves inoculated intrabronchially with Mann-
heimia haemolytica (lanes 2, 4, 6, 7) or saline (lanes 3 and
5) and then euthanatized 6 hours after inoculation. Proteins
were separated on a 12.5% SDS-PAGE by electrophoresis
and transferred to PVDF membranes. A monoclonal anti-
body (IG9-IC2) against AP is immunoreactive to several
fragments of different sizes that are also seen in the western
blots of sheep and man. The 31.0-kd band is most consis-
tently immunoreactive. Broad-range molecular weight mark-
ers are shown in lane 1. Note the similarities in band size
despite the different treatments, indicating a lack of induced
expression.
bated for 30 minutes at room temperature with biotinylated
goat anti-mouse IgG, 1 : 400 dilution (Vector, Burlingname,
CA). Slides were rinsed in wash buffer (BioGenex, San Ra-
mon, CA), and then alkaline-phosphatase–conjugated strep-
tavidin (BioGenex) was applied for 30 minutes. Slides were
rinsed and then exposed to chromagen (Vector Red, Vector)
for 18 minutes, rinsed, counter-stained (1/4 strength hema-
toxylin), and coverslipped. Specificity of antibody affinity
with tissue sections was determined by preincubating the
primary antibody with varying concentrations of synthetic
AP. Three types of negative controls were used, and all
lacked immunoreactivity: 1) control sections that were not
incubated with primary antibody, 2) the primary antibody
was incubated with the synthetic AP (HO–DDDDDDD–H)
before tissue application (see also below), and 3) mouse
preimmune serum was substituted for primary antibody.
Distribution of AP-IR
The cellular distribution of AP-IR was determined by light
microscopy of sections stained by immunohistochemistry,
defined, and compared with the AP-IR distribution in human
and ovine lung.
Intensity of AP-IR
The intensity of AP-IR was assessed and characterized by
light microscopy. Intensity of staining was scored on a sub-
jective scale where 0  no AP-IR; 1  10% of cells (of
bronchi, bronchiole, alveolus, vessel) had AP-IR; 2  10–
30% of cells had AP-IR; 3  30–60% of cells had AP-IR;
and 4  60–90% of cells had AP-IR. Five 20 fields per
tissue of lung from at least two sections of lung per animal
were scored.
Scoring of inflammation intensity
Inflammation intensity was assessed in a predetermined
scoring system at 20 magnification, where 0  no inflam-
matory cells, 1  detectable infiltrates of neutrophils in air-
ways, 2  5 neutrophils in 10% and 30% of alveolar
and airway lumens, 3  5 neutrophils in 30% of alveolar
and airway lumens, and 4  filling of alveolar and airway
lumens with exudates. Five 20 fields per tissue of lung
from at least two sections of lung per animal were scored.
Anionic peptide specificity
Assessment of antibody specificity. Antibody specificity
was previously assessed with a competitive ELISA.6,7,18 Brief-
ly, BSA-DDDDDDD–OH conjugate (50 ng conjugate/well)
was used as the adsorbed antigen, and varying graded con-
centrations (1.0–0.002 mM) of H–DDDDDDD–OH, H–
GADDDDD–OH, H–VDDDDK–OH, H–TQDDGGK–OH,
H–GGEEK–OH, and H–SGSGSGS–OH were used as com-
petitive antigens in the presence of 1G9-1C2. 1G9-1C2 was
specific for peptides with C-terminus Asp residues. The an-
tibody recognized H–GADDDDD–OH nearly as well as H–
DDDDDDD–OH. But H–VDDDDK–OH, H–TQDDGGK–
OH, H–GGEEK–OH, and H–SGSGSGS–OH were not rec-
ognized and did not cross-react.
Identification of antibody epitopes. The epitope-binding
site of the antibody was also previously determined.6–8 Thirty
peptides (7 residues each) corresponding to a single residue
frameshift of the sequence were synthesized simultaneously
on a derivatized cellulose sheet (SPOTs, Genosys, Wood-
lands, TX). Antibody 1G9-1C2 recognized epitopes that con-
tained greater than 2 C-terminal Asp residues.
Immunocytochemistry. The specificity of the monoclonal
was previously determined.19 Briefly, control tissue sections
were incubated without antibody 1G9-1C2 or with antibody
1G9-1C2 preincubated with 0.5 mM H–DDDDDDD–OH. In
both these controls, specific staining of APs could not be
detected.
Statistical analysis
Inflammation, intensity, and distribution scores were an-
alyzed by the chi-square test and Fisher’s exact test. The
significance level used was 0.10.
Results
Western blots of lung from calves and an adult cow
In the western blots of lung homogenates from all
neonatal calves (Fig. 1) and an adult cow, five bands
were detected regardless of inocula: 28–30 (strongest
signal), 31, 45, and 52–60 kd (in calves only); in the
western blot of the cow, additional bands were present
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Fig. 2. Control lung lacking inflammation from calf in-
oculated with PFS 6 hours after inoculation. Multifocal bron-
chiolar epithelial cells have relatively increased cytoplasmic
and/or nuclear immunoreactivity for AP. Hematoxylin coun-
terstain. Bar  30 m.
Fig. 3. Lung from calf infected with M. haemolytica 6
hours after inoculation. The bronchiolar lumen contains nu-
merous neutrophils, and in the epithelium there is minimal/
mild immunoreactivity for AP (red) in multifocal nuclei and,
to a lesser degree, the cytoplasm of bronchiolar epithelial
cells. Neutrophils and exudate lack immunoreactivity. He-
matoxylin counterstain. Bar  25 m.
at 35–38 and 64 kd (not shown). These band sizes are
consistent with those seen in lung of sheep and man.5,6
Similar findings were present in lung homogenates of
calves similarly inoculated with P. aeruginosa, killed
P. aeruginosa, and P. aeruginosa LPS (not shown).
Distribution of AP-IR
Control lung (PFS-inoculated animals). Lung tissue
from control (PFS-inoculated), neonatal, and growing
(3-month-old) calves lacked inflammatory cells or oth-
er lesions. The distribution of AP-IR was similar be-
tween neonatal and growing calves, and it was similar
to that of human and ovine lung stained for AP-IR. In
bronchi, intense staining in the nuclei of multifocal
bronchial epithelial cells was present in all age groups.
AP-IR was also present in the apical cytoplasm of
most cells in the pseudostratified epithelium of bron-
chial mucosa. In most areas of bronchial epithelium,
there was intense staining (nuclear, cytoplasmic, or
both) of multifocal, individual bronchial epithelial
cells, whereas adjacent cells completely lacked stain-
ing. Nuclei of multifocal cells of the bronchial sub-
mucosal glands were immunoreactive for AP, but sub-
mucosal gland cells lacked cytoplasmic AP-IR.
In bronchioles of neonatal and 3-month-old calves,
AP-IR was present in nuclei of multifocal cells and in
the apical cytoplasm of multifocal epithelial cells (Fig.
2). AP-IR was present in the nucleus and was only
sporadically present in the cytoplasm of alveolar epi-
thelial cells. In all age groups, nuclear AP-IR of ar-
terial and bronchial smooth muscle cells was present,
and cytoplasmic AP-IR was rare. AP-IR was distrib-
uted randomly in the smooth muscle cells, and it did
not have a consistent or discernable pattern of staining
within the layers of the bronchi or in the vascular wall.
Inflamed lung (M. haemolytica, LPS, and LPS-P–in-
oculated animals). No inflammatory infiltrates were
present in the tissues of control (PFS-inoculated) ani-
mals (Tables 1, 2). Inflammatory lesions consistent with
M. haemolytica pneumonia were present in animals that
receivedM. haemolytica andM. haemolytica LPS. Only
minimal infiltrates of neutrophils were present in ani-
mals inoculated with M. haemoltyica LPS-P.
Inoculation with M. haemolytica, LPS, or LPS-P did
not alter AP-IR distribution in bronchi of neonatal and
growing (3-month-old) calves. In bronchioles of in-
oculated neonatal and growing calves, the distribution
of nuclear and cytoplasmic staining was decreased
(fewer cells stained, Fig. 3) when compared with bron-
chioles containing inflammatory cells (Tables 1, 2), but
the decrease was not statistically significant. Lungs in-
oculated with M. haemolytica and LPS had the highest
degree of inflammatory exudate, yet fibrinous exudate
and neutrophils in the lumen lacked AP-IR. Nuclei of
multifocal lymphocytes within the lamina propria and
adventitia of bronchi were immunoreactive for AP, but
neutrophils within the bronchial lumina lacked AP-IR.
AP-IR was not reduced in alveoli that contained in-
flammatory exudate.
Intensity of AP-IR in control and inflamed lung
AP-IR intensity was not changed in bronchi and al-
veoli but decreased slightly in bronchioles of both neo-
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Table 1. Intensity of inflammation and distribution and
intensity of AP-IR in lungs of growing (3 months old) cattle
24 hours after intrabronchial inoculation of PFS, M. hae-
molytica LPS-P, M. haemolytica LPS, and M. (Pasteurella)
haemolytica.
Inoculum*
Intensity of
Inflammation
Distribution
of AP-IR†
Intensity of
AP-IR
PFS
LPS-P
LPS
M. haemolytica
0
1
2
2
3
3
3
2
3
3
2
2
* Two animals were present in each group. Inflammation and AP-
IR intensities were assessed in a predetermined scoring system out-
lined in Materials and Methods.
† Changes in AP-IR distribution and intensity were only present
in bronchiolar epithelial cells.
Table 2. Intensity of inflammation and distribution and
intensity of AP-IR in lungs of neonatal calves inoculated
with either PFS or M. haemolytica.
Inoculum*
Intensity of
Inflammation
Distribution
of AP-IR†
Intensity of
AP-IR
PFS
M. haemolytica
0
4
3
2
3
2
* Four animals were present in each group. Inflammation and AP-
IR intensities were assessed in a predetermined scoring system de-
scribed in Materials and Methods.
† Changes in AP-IR distribution and intensity were only present
in bronchiolar epithelial cells.
natal and growing animals with evidence of inflam-
matory infiltrates when compared with control (PFS-
inoculated) animals (Tables 1, 2; Fig. 3). This de-
crease, however, was also not statistically significant.
The degree of AP-IR was similar between animals in
each group.
Discussion
In this study, AP-IR was widespread in the lungs of
neonatal and growing (3-month-old) calves in both
control and acutely inflamed tissue. Also, the distri-
bution and the western blots of AP-IR in lung tissue
of cattle were similar to those of previously described
lung in human and sheep.5,6 But the concentration of
antibody required to detect AP-IR by immunohisto-
chemistry in the sheep lung is the lowest of the three
species. This may be because of the greater avidity of
the antibody to ovine AP, the availability of AP in
ovine tissue sections, or the amount of AP in ovine
tissues. The antibody may have higher avidity for
ovine AP because the exact structure of the possible
precursor molecules in cattle, sheep, and humans is
currently unknown (see discussion below). Respiratory
epithelial cells of all three species produce APs, indi-
cating that APs are present in a location where anti-
microbial activity would be most effective against mi-
crobial colonization.
AP-IR distribution and intensity were not increased,
and, in contrast, appeared decreased in the nuclei and
cytoplasm of bronchiolar epithelial cells of neonatal
and growing calves inoculated with M. haemolytica
and growing calves inoculated with M. haemolytica
LPS. M. haemolytica LPS-P incited only mild inflam-
matory infiltrates and also lacked changes in AP-IR
distribution and intensity as compared with controls.
The inability of AP-IR to increase in this study indi-
cates that APs are not induced by live bacteria, bac-
terial LPS, or the acute inflammatory response. This
is in sharp contrast to bovine LAP, a -defensin, which
is markedly increased in the same species (bovine) and
breed (Holstein) with the same inoculum (M. haemo-
lytica) in the same laboratory.23 This suggests that APs
are constitutively produced and rapidly expended dur-
ing acute pulmonary inflammation. AP is present in
high concentrations in BAL fluid of humans,4 sheep,5
and cattle8 and may be an important antimicrobial fac-
tor during the initial stages of microbial colonization
and infection. The rapid availability of AP may allow
time for other inducible antimicrobial peptides, such
as HBD-2 in man, LAP and TAP in the bovine, to be
transcribed and translated. Although some cationic an-
timicrobial peptides may inhibit/dampen the inflam-
matory response,14,15 it is possible that AP, with its an-
ionic charge and small size, may not affect this process
and may therefore allow development of the inflam-
matory response during the earliest stages of microbial
colonization and infection. Some recent work suggests
that AP expression is dependent on the state of epi-
thelial cell differentiation. During the more chronic
(repair) stages of bacterial pneumonia, epithelial cells
undergoing hyperplasia have increased AP in compar-
ison with well-differentiated, mature cells.11 An in-
crease of AP in hyperplastic cells during chronic pneu-
monia may be due to increased basal expression, in-
creased cytoplasmic storage, or a lack or release/se-
cretion of APs.11
The western blots suggest that APs (as intact zy-
mogens) were present in the neonatal and growing an-
imals as well as in adult animals. Several types of
proteins, including nucleosomal proteins, contain po-
lyaspartate regions that may be detected by the IG9-
IC2 monoclonal antibody. For example, nonhistone
acidic proteins that bind to chromatin, known as the
high-mobility group (HMG) proteins, are present in
the nucleus. These proteins have long stretches of acid-
ic amino acid sequences, with some stretches of up to
40 aspartic acid and glutamic acid residues.24 HMG
and other types of proteins may release APs as a nor-
mal part of cellular metabolism or maturity; but the
exact protein or proteins that release forms of AP that
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have antimicrobial activity are not known, nor are the
cleavage processes that liberate active APs. Additional
work with these proteins is necessary to determine
more precisely which protein(s) releases APs with an-
timicrobial activity. Despite this, the study demon-
strates that cattle lung epithelia express APs in a sim-
ilar distribution to sheep and man.5,6 The work dem-
onstrates that a subset of and not all the respiratory
epithelial cells express APs and that expression is not
increased by inflammatory stimuli such as live bacte-
ria, LPS, or an LPS-P. Therefore, there are precise re-
gions of AP production within the lung, and the pro-
duction is likely constitutive.
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